aiqbench analysis
This research demonstrates a hybrid quantum-classical approach for molecular docking, mapping the problem to a maximum vertex-weighted clique formulation solvable via variational circuits on current NISQ devices. By proving that global minimizers can be represented as pure product states, the authors provide a rigorous foundation for using unitary variational optimization in structure-based drug design. The successful execution on an IBM quantum computer validates the feasibility of leveraging quantum-assisted methods to tackle computationally intensive combinatorial problems in computational biology.
Resource-Efficient Bio-Molecular Docking on a NISQ-era Digital Quantum Computer
arXiv:2608.19868v1 Announce Type: new Abstract: Molecular docking is a vital computational task in drug discovery, wherein the objective is to efficiently identify optimal binding poses between a ligand and a target receptor protein. Due to the combinatorial explosion of possible binding configurations, docking of large and flexible molecules remains a computationally intensive problem, especially at scale. Early studies have revealed that the molecular docking can be re-cast as a maximum vertex-weighted clique problem (MVWCP) problem on a compatibility graph to be solved classically. In this work, we proposed a hybrid quantum-classical approach for molecular docking leveraging the MVWCP formalism with a variational full-basis encoding (FBE) strategy, which enables efficient encoding of classical binary variables with Bloch sphere vectors. We further prove that a global minimizer of the FBE objective can always be chosen to be a pure product state, thereby providing a rigorous justification for its optimization using a unitary variational circuit. The molecular docking problem is first mapped to a cost Hamiltonian that is minimized within a variational framework, optimized via a randomized imaginary time evolution (ITE)-inspired warm start, and gradient-based techniques. Finally, we also executed the circuit on an IBM quantum computer, underlying the feasibility and of quantum-assisted optimization for structure-based drug design and point towards the broader utility of advanced encoding techniques in quantum optimization for computational biology.
Abstract:Molecular docking is a vital computational task in drug discovery, wherein the objective is to efficiently identify optimal binding poses between a ligand and a target receptor protein. Due to the combinatorial explosion of possible binding configurations, docking of large and flexible molecules remains a computationally intensive problem, especially at scale. Early studies have revealed that the molecular docking can be re-cast as a maximum vertex-weighted clique problem (MVWCP) problem on a compatibility graph to be solved classically. In this work, we proposed a hybrid quantum-classical approach for molecular docking leveraging the MVWCP formalism with a variational full-basis encoding (FBE) strategy, which enables efficient encoding of classical binary variables with Bloch sphere vectors. We further prove that a global minimizer of the FBE objective can always be chosen to be a pure product state, thereby providing a rigorous justification for its optimization using a unitary variational circuit. The molecular docking problem is first mapped to a cost Hamiltonian that is minimized within a variational framework, optimized via a randomized imaginary time evolution (ITE)-inspired warm start, and gradient-based techniques. Finally, we also executed the circuit on an IBM quantum computer, underlying the feasibility and of quantum-assisted optimization for structure-based drug design and point towards the broader utility of advanced encoding techniques in quantum optimization for computational biology.
Quantum Physics (quant-ph); Soft Condensed Matter (cond-mat.soft); Chemical Physics (physics.chem-ph); Biomolecules (q-bio.BM)
arXiv:2608.19868 [quant-ph]
(or arXiv:2608.19868v1 [quant-ph] for this version)
https://doi.org/10.48550/arXiv.2608.19868 Focus to learn more arXiv-issued DOI via DataCite (pending registration)
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.
Full text under the publisher's open licence · 319 words
Related coverage

Researchers Accelerate Drug Discovery with Quantum Computing
Quantum Zeitgeist · Aug 23, 2026

News
Quantum Computing Report · Jun 7, 2026

News
Quantum Computing Report · Jul 25, 2026

Researchers Use IBM Quantum Computer to Test Drug-Docking Method
The Quantum Insider · Aug 27, 2026